Skip to main content

Table 3 Stepwise regression analysis final model of the total and individual domains of the HAEMO-QoL-A and Manchester Oxford foot and ankle Questionnaire (MOXFQ)

From: Decline in health-related quality of life and foot and ankle patient reported outcomes measures in patients with haemophilia and ankle haemarthropathy

Outcome measure

Variable

Unstandardized Coefficients

B

Sig

95% Confidence Interval

Lower bound

Upper bound

Haemo-Qol-A total score

NPRS six months

0.76

 < 0.001

0.56

0.98

Inhibitor status

4.14

0.001

1.68

6.55

Physical function

NPRS six months

0.05

0.003

0.02

0.09

Factor product

-0.50

0.009

-0.08

-0.01

On demand treatment

0.31

0.013

0.07

0.56

Role function

NPRS six months

0.22

 < 0.001

0.16

0.28

Inhibitor status

0.85

0.018

0.15

1.55

Worry

NPRS six months

0.24

 < 0.001

0.18

0.31

Inhibitor status

0.79

0.041

0.03

1.55

Bleeding

NPRS six months

0.19

 < 0.001

0.12

0.25

Inhibitor status

1.04

0.005

0.30

1.79

Emotion

NPRS six months

-0.11

 < 0.001

-0.162

-0.06

MOXFQ (foot and ankle) total score

NPRS six months

6.84

 < 0.001

5.88

7.80

Inhibitor status

11.39

0.048

0.12

22.65

Walking/ standing

NPRS six months

1.85

 < 0.001

1.50

2.20

HJHS right

0.23

0.021

0.04

0.43

Pain

NPRS six months

1.40

 < 0.001

1.22

1.59

Social

NPRS six months

1.05

 < 0.001

0.89

1.24

Inhibitor status

2.85

0.011

0.67

5.04